Enbrel etanercept: Phase IV data

A 3-year, open-label, U.S. and Canadian Phase IV trial in 602 children with polyarticular or systemic juvenile idiopathic arthritis (JIA) reported no cases of lymphoma, malignancy, tuberculosis or dea...